Trial Site Detail
Drug: |
IDRX-42 |
|||
|---|---|---|---|---|
Trial: |
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
H. Lee Moffit Cancer Center12902 USF Magnolia Dr. |
Principal Investigator: |
Mauricio Ribeiro |
|---|---|
Contact: |
813-745-4673 New patient: contactus@moffitt.org 888-663-3488 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
H. Lee Moffit Cancer Center Website: |
http://www.moffitt.org/Site.aspx?spid=BF72D4455066450A96F788D72D1E2187&type=PhysSearchByProg&progname=Sarcoma&SearchType=Physician |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.